Profile picture

Associate Professor Andreas Kalogeropoulos

Stony Brook University, Stony Brook (United States of America)
Membership: ESC Professional Member
Follow
Biography
Andreas Kalogeropoulos, MD MPH PhD FACC FHFSA FASE, is an Associate Professor of Medicine (Cardiology) at Stony Brook University, NY. He is a clinical and outcomes researcher with focus on heart failure, echocardiography, and research methodology. Dr. Kalogeropoulos received his MD (1994) and trained in cardiovascular medicine (2004) at the University of Patras, Greece. He trained in echocardiography and heart failure at Emory University (Atlanta, GA), where he joined faculty in 2010 and received his MPH in 2013. Dr. Kalogeropoulos has authored over 150 peer-reviewed articles and 3 book chapters. He has received research support from the National Institutes of Health, the American Heart Association, and the American Society of Echocardiography, among others, for his work on heart failure and echocardiography. He has served on the Research Committees of the Heart Failure Society of America (Chair), the American Society of Echocardiography, and the National Cardiovascular Data Registry.
Logo ESC

Contributor content

One-year cardiovascular outcomes before and after GLP-1 ra discontinuation: a real-world retrospective cohort study
Presentation
One-year cardiovascular outcomes before and after GLP-1 ra discontinuation: a real-world retrospective cohort study
Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study
Presentation
Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study
The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data
Presentation
The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data
Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis
Presentation
Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis
Medications profile post hospitalization for acute heart failure
Presentation
Medications profile post hospitalization for acute heart failure

ESC 365 is supported by